Amphastar Pharmaceuticals Announces Board and Compensation Changes

TL;DR

Amphastar's board shuffled, exec pay tweaked. Watch for new strategy.

AI Summary

Amphastar Pharmaceuticals, Inc. announced on July 18, 2025, changes in its board of directors and executive compensation. Specifically, the company reported the departure of a director and the election of a new director, along with updates to certain officers' compensatory arrangements.

Why It Matters

Changes in a company's board and executive compensation can signal shifts in strategy, governance, or financial outlook, impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — The filing details routine corporate governance changes and compensation adjustments, which typically carry low immediate risk.

Key Players & Entities

• Amphastar Pharmaceuticals, Inc. (company) — Registrant
• July 18, 2025 (date) — Date of earliest event reported
• Delaware (jurisdiction) — State of incorporation
• Rancho Cucamonga, California (location) — Principal executive offices

FAQ

From the Filing

0001297184-25-000040.txt : 20250721 0001297184-25-000040.hdr.sgml : 20250721 20250721161421 ACCESSION NUMBER: 0001297184-25-000040 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250718 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20250721 DATE AS OF CHANGE: 20250721 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Amphastar Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001297184 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 330702205 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36509 FILM NUMBER: 251137434 BUSINESS ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 BUSINESS PHONE: 909-980-9484 MAIL ADDRESS: STREET 1: 11570 SIXTH STREET CITY: RANCHO CUCAMONGA STATE: CA ZIP: 91730 8-K 1 amph-20250718x8k.htm 8-K _ 0001297184 false 0001297184 2025-07-18 2025-07-18 ​ ​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K ​ ​ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 ​ Date of Report (Date of earliest event Reported): July 18, 2025 ​ Amphastar Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in Charter) ​ ​ ​ ​ ​ Delaware 001-36509 33-0702205 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification Number) ​ ​ ​ ​ 11570 6th Street ​ Rancho Cucamonga , California 91730 (Address of Principal Executive Offices) (Zip Code) ​ Registrant's telephone number, including area code: ( 909 ) 980-9484 ​ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ​ ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) ​ Securities registered pursuant to Section 12(b) of the Act: ​ T ​ ​ ​ ​ ​ ​ Title of each class ​ Trading Symbol(s) ​ Name of each exchange on which registered ​ ​ ​ ​ Common Stock, par value $0.0001 per share ​ AMPH ​ The Nasdaq Stock Market LLC ​ ​ ​ ​ ​ ​ ​ ​ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 ( § 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 ( § 240.12b-2 of this chapter). ​ Emerging growth company ☐ ​ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ ​ ​ ​ ​ ​ ​ ​ ​ ​ Item   5.02.   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers . ​ On July 18, 2025, the Board of Directors (the “Board”) of Amphastar Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), approved an increase to the authorized number of directors permitted t